FR2910318B1 - Dispersion de polyaminoacides dans une phase lipidique continue. - Google Patents

Dispersion de polyaminoacides dans une phase lipidique continue.

Info

Publication number
FR2910318B1
FR2910318B1 FR0611186A FR0611186A FR2910318B1 FR 2910318 B1 FR2910318 B1 FR 2910318B1 FR 0611186 A FR0611186 A FR 0611186A FR 0611186 A FR0611186 A FR 0611186A FR 2910318 B1 FR2910318 B1 FR 2910318B1
Authority
FR
France
Prior art keywords
polyaminoacids
dispersion
lipid phase
continuous lipid
continuous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0611186A
Other languages
English (en)
Other versions
FR2910318A1 (fr
Inventor
Gauthier Pouliquen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0611186A priority Critical patent/FR2910318B1/fr
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Priority to US12/003,095 priority patent/US20080152675A1/en
Priority to CA002670453A priority patent/CA2670453A1/fr
Priority to PCT/EP2007/064352 priority patent/WO2008074871A1/fr
Priority to JP2009542071A priority patent/JP2010513407A/ja
Priority to EP07857971A priority patent/EP2101728A1/fr
Priority to CNA2007800466480A priority patent/CN101563066A/zh
Publication of FR2910318A1 publication Critical patent/FR2910318A1/fr
Application granted granted Critical
Publication of FR2910318B1 publication Critical patent/FR2910318B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0611186A 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue. Expired - Fee Related FR2910318B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0611186A FR2910318B1 (fr) 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue.
CA002670453A CA2670453A1 (fr) 2006-12-20 2007-12-20 Dispersion de polyaminoacides dans une phase lipidique continue
PCT/EP2007/064352 WO2008074871A1 (fr) 2006-12-20 2007-12-20 Dispersion de polyaminoacides dans une phase lipidique continue
JP2009542071A JP2010513407A (ja) 2006-12-20 2007-12-20 連続脂質相中のポリアミノ酸の分散液
US12/003,095 US20080152675A1 (en) 2006-12-20 2007-12-20 Dispersion of polyamino acids in a continuous lipid phase
EP07857971A EP2101728A1 (fr) 2006-12-20 2007-12-20 Dispersion de polyaminoacides dans une phase lipidique continue
CNA2007800466480A CN101563066A (zh) 2006-12-20 2007-12-20 聚氨基酸在连续脂相中的分散体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0611186A FR2910318B1 (fr) 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue.

Publications (2)

Publication Number Publication Date
FR2910318A1 FR2910318A1 (fr) 2008-06-27
FR2910318B1 true FR2910318B1 (fr) 2009-07-03

Family

ID=37895994

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0611186A Expired - Fee Related FR2910318B1 (fr) 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue.

Country Status (7)

Country Link
US (1) US20080152675A1 (fr)
EP (1) EP2101728A1 (fr)
JP (1) JP2010513407A (fr)
CN (1) CN101563066A (fr)
CA (1) CA2670453A1 (fr)
FR (1) FR2910318B1 (fr)
WO (1) WO2008074871A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2892725B1 (fr) * 2005-10-31 2011-03-04 Flamel Tech Sa Acides polyglutamiques fonctionnalises par des derives de l'histidine et des groupements hydrophobes et leurs applications notamment therapeutiques
CN103215125B (zh) * 2013-04-10 2014-07-02 陕西科技大学 一种油包水纳米乳液的制备方法
CN103211281B (zh) * 2013-04-10 2015-01-28 陕西科技大学 一种抗氧化油包水微乳液的制备方法
ES2502691B1 (es) * 2013-09-25 2015-07-07 Sani-Red, S.L. Método de conservación y estabilización de proteínas, aplicable para desarrollos industriales de formulaciones de productos sanitarios, farmacéuticos y cosméticos
EA201692083A1 (ru) 2014-04-16 2017-03-31 Вейкс-Фарма Гмбх Фармацевтическая композиция для ветеринарии и ее применение
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
FR3083088B1 (fr) * 2018-06-29 2020-10-02 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
EP3740195A1 (fr) 2017-12-07 2020-11-25 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
KR20240171194A (ko) * 2017-12-07 2024-12-06 아도시아 아밀린, 아밀린 작용제 수용체 또는 아밀린 유사체 및 코-폴리아미노산을 포함하는 주사용 수용액 형태의 조성물
BR112020011479A2 (pt) 2017-12-07 2020-11-17 Adocia composições na forma de uma solução aquosa injetável caracterizada pelo fato de que compreende amilina, um agonista do receptor de amilina ou um análogo de amilina e um co-poliaminoácido
MX2020005914A (es) 2017-12-07 2020-10-19 Adocia Solución inyectable con un ph 7 de 7 que incluye al menos una insulina basal con un pi de entre 5.8 y 8.5 y un copoliaminoácido con cargas de carboxilato y radicales hidrofóbicos.
IL275192B2 (en) * 2017-12-07 2025-06-01 Adocia Injectable solution at ph 7 comprising at least one basal insulin having a pi of between 5.8 and 8.5 and a copolyamino acid carrying carboxylate charges and hydrophobic radicals
JP7637965B2 (ja) 2017-12-07 2025-03-03 アドシア ５．８～８．５のｐＩを有する少なくとも１つの基礎インスリンならびにカルボキシレート電荷および疎水性ラジカルを有するコポリアミノ酸を含むｐＨ７の注射溶液
JP6582084B2 (ja) * 2018-03-22 2019-09-25 ライオン株式会社 口腔用組成物
CN111603441B (zh) * 2020-07-01 2022-11-25 瑞希(重庆)生物科技有限公司 一种两亲性聚氨基酸共聚物/泊洛沙姆温敏凝胶及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06128149A (ja) * 1992-09-04 1994-05-10 Japan Tobacco Inc 水溶性物質を含有してなるｗ／ｏ型エマルジョン及び油剤
FR2702373B1 (fr) * 1993-03-08 1996-06-07 Rhone Merieux Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.
FR2732218B1 (fr) * 1995-03-28 1997-08-01 Flamel Tech Sa Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
ATE438382T1 (de) * 2001-02-28 2009-08-15 Intervet Int Bv Wasser-in-öl-injektionsemulsionen
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
WO2005094789A1 (fr) * 2004-03-31 2005-10-13 Aspion Co., Ltd. Preparation pharmaceutique de type s/o et procede de production associe

Also Published As

Publication number Publication date
JP2010513407A (ja) 2010-04-30
FR2910318A1 (fr) 2008-06-27
CA2670453A1 (fr) 2008-06-26
CN101563066A (zh) 2009-10-21
US20080152675A1 (en) 2008-06-26
WO2008074871A1 (fr) 2008-06-26
EP2101728A1 (fr) 2009-09-23

Similar Documents

Publication Publication Date Title
DE602007013341D1 (de) Phasenwechseltinten
EP2050013A4 (fr) Distribution des services dans les calculs basés sur des graphes
EP2167999A4 (fr) Affichage composite
EP2035995A4 (fr) Application de contraintes géographiques dans une distribution de contenu
DE602008001460D1 (de) Flüssigkristallanzeige
DE602007010066D1 (de) Flüssigkristallanzeige
DK2122344T3 (da) Lipiddobbeltlags-sensorsystem
DE602007006531D1 (de) Pyrazin-2-carboxamid-derivate als cb2-rezeptormodulatoren
FR2925118B1 (fr) Panneau de support d'abradable dans une turbomachine
BRPI0811551A2 (pt) Articulação de quatro pontos
EP2201025A4 (fr) Produits de construction lipidiques fonctionnels
EP2126821A4 (fr) Facteurs d'incitation au partage du marché
DE602007004038D1 (de) Flüssigkristallanzeige
BRPI0906881A2 (pt) Articulação de direção
BRPI0815376A2 (pt) Dextrose diretamente compresível
FR2933126B1 (fr) Actionnement d'un inverseur de poussee dans une turbomachine
DE602008000227D1 (de) Flüssigkristallanzeige
PT1712517E (pt) Reação em fase sólido-gasosa
EP2155914A4 (fr) Améliorations dans la production de ferroalliages
FR2913480B1 (fr) Joint tournant
EP2064485A4 (fr) Conducteurs thermiques integres dans une lunette
AU2007209465A8 (en) Acyclic sulfamide derivatives
EP2120340A4 (fr) Déphaseur
DE602008003594D1 (de) Phasenwechseltinte
DE602007011413D1 (de) Phasenregelkreiselement

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829